A biotechnology solution that uses Phospholipid:Diacylglycerol Acyltransferase (PDAT) gene overexpression to improve heat stress tolerance in canola while maintaining or increasing seed oil content, yield, and quality. This addresses a critical vulnerability in canola cultivation and offers value-added improvements to the oilseed value chain.
Canola is a major oilseed crop whose value chain depends heavily on seed oil production, yet it is vulnerable to heat stress, which can reduce both yield and oil quality. This research proposes overexpressing the Brassica napus Phospholipid:Diacylglycerol Acyltransferase (BnaPDAT) gene to simultaneously enhance heat stress tolerance and maintain or increase seed yield and oil content. PDAT catalyzes the final step in acyl-CoA independent triacylglycerol biosynthesis, a pathway critical for seed oil accumulation and stress resilience in related plant species.
This approach offers canola breeders, seed companies, and oilseed processors a potential pathway to more resilient crops with stable or improved oil output under elevated temperature conditions. The technology is relevant for growers facing increasing climate variability and for industry stakeholders seeking differentiated, high-performing canola varieties.
Key features:
Validation approach:
The project is at an early-to-mid stage of development. Homologous canola plants overexpressing BnaPDAT have been successfully generated and confirmed, with seeds harvested and ready for greenhouse cultivation. The next phase involves a one-year greenhouse validation study to assess heat tolerance and seed quality traits. All required facilities and expertise are available in the researcher's laboratory at the University of Alberta. Commercial deployment would require subsequent field trials, regulatory review, and breeding integration.
The University of Alberta is a large, comprehensive public research university in Edmonton with multiple campuses and a strong applied research culture. Industry engages through co-located labs and pilot-scale facilities, as well as established co-op and internship programs that place talent with partners year-round. Integration with Alberta’s province-wide hospital system supports clinical research and accelerates translation. Companies also benefit from proximity to regional industry clusters and collaboration hubs on and near campus for joint R&D and prototyping. Supported by NSERC, CIHR, SSHRC, and Canada Foundation for Innovation funding—plus provincial and industry support—the tech transfer office manages IP, licensing, and startup formation with streamlined sponsored-research agreements.